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T loops and telomeric G-quadruplex (G4) DNA struc-
tures pose a potential threat to genome stability and
must be dismantled to permit efficient telomere repli-
cation. Here we implicate the helicase RTEL1 in the
removal of telomeric DNA secondary structures,
which is essential for preventing telomere fragility
and loss. In the absence of RTEL1, T loops are inap-
propriately resolved by the SLX4 nuclease complex,
resulting in loss of the telomere as a circle. Depleting
SLX4 or blocking DNA replication abolished telomere
circles (TCs) and rescued telomere loss in RTEL1/
cells but failed to suppress telomere fragility.
Conversely, stabilization of telomeric G4-DNA or
loss of BLM dramatically enhanced telomere fragility
in RTEL1-deficient cells but had no impact on TC
formation or telomere loss. We propose that RTEL1
performs two distinct functions at telomeres: it
disassembles T loops and also counteracts telo-
meric G4-DNA structures, which together ensure
the dynamics and stability of the telomere.
INTRODUCTION
Telomeres are complex nucleoprotein structures, which function
to maintain and protect the ends of linear chromosomes.
Mammalian telomeres are composed of tandem repeats of
TTAGGG sequences, which terminate in a 30 single-stranded
overhang (de Lange, 2005). Telomere-repeat length can be
maintained by the action of telomerase or by an alternative telo-
mere length (ALT) maintenance mechanism that utilizes homolo-
gous recombination in 10% of cancer cells (Bryan et al., 1997;
Greider and Blackburn, 1985). Telomere function is also critically
dependent on shelterin, a protein complex comprising telomere-
specific binding proteins including TRF1, TRF2, and POT1 that
function to regulate telomerase and protect the chromosome
end (de Lange, 2005).
Visualization of vertebrate telomeres by electron microscopy
revealed that telomeres frequently adopt a lasso-like configura-
tion called a T loop (Griffith et al., 1999). T loop structures alsoexist in other eukaryotes (Cesare et al., 2003; Mun˜oz-Jorda´n
et al., 2001; Raices et al., 2008), and their formation requires
both homologous recombination (HR) and shelterin components
(Verdun and Karlseder, 2006). The T loop is therefore believed to
result from strand invasion of the 30 single-stranded telomeric
end into subtelomeric duplex TTAGGG repeats, which results
in a displacement loop (D loop) intermediate at the site of strand
invasion (Amiard et al., 2007). It has been proposed that T loops
protect the chromosome end from degradation and promis-
cuous DNA-repair activities (de Lange, 2005), but evidence
that T loops form at all telomeres and perform a protective func-
tion is currently lacking. Irrespective of the nature of T loops,
these structures must be removed to permit telomere replica-
tion, but the mechanistic basis of T loop disassembly remains
unclear (Gilson and Ge´li, 2007).
Fragile sites are specific chromosomal loci that exhibit gaps or
breaks when cells are subjected to low doses of aphidicolin,
which induces replication stress (Durkin and Glover, 2007).
Fragile sites are hot spots for deletions and other chromosome
rearrangements and are associated with an increased frequency
of HR (Glover and Stein, 1987). Recently, telomeres have been
identified as aphidicolin-induced fragile sites (Sfeir et al., 2009).
TRF1 and the DNA helicases RTEL1 and BLM are required to
prevent telomere fragility, but how they do so is uncertain (Sfeir
et al., 2009). It was proposed that TRF1, RTEL1, and BLM may
facilitate telomere replication by removing telomeric G-quadru-
plex (G4) DNA structures (Sfeir et al., 2009). However, the
contribution of telomeric G4-DNA structures to telomere fragility
has not been addressed.
RTEL1 (regulator of telomere length) is a helicase first identi-
fied by genomic mapping of loci that control telomere-length
differences between M. musculus and M. spretus (Zhu et al.,
1998). RTEL1 plays an essential role in genome stability as
knockout mice are embryonic lethal and cells derived from these
mice exhibit impaired proliferation, chromosomal abnormalities,
and telomere loss, but the molecular basis of this defect remains
unclear (Ding et al., 2004). RTEL1 was also recently identified in
a genome-wide association study as a susceptibility locus for
glioma, highlighting its importance for genome integrity (Egan
et al., 2011; Shete et al., 2009). RTEL1 was also independently
identified as an antagonist of HR with functional similarity to
the yeast antirecombinase Srs2 (Marini and Krejci, 2010).
Because human RTEL1 exhibits D loop dissociation activityCell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc. 795
in vitro, it was proposed that the phenotypes associated with
RTEL-1/RTEL1 deficiency reflect a defect in dismantling recom-
bination intermediates (Barber et al., 2008; Youds et al., 2010),
but how this function contributes to tumorigenesis is not known.
In this work, we have investigated the underlying cause of telo-
mere dysfunction in RTEL1-deficient cells. We present evidence
that RTEL1 is essential for the disassembly of T loops during
DNA replication. Failure to dismantle T loops in RTEL1-deficient
cells leads to rapid changes in telomere length and telomere loss
as a result of catastrophic telomere processing by the SLX4
nuclease complex, which resolves the T loop as a circle. We
define a general mechanism of telomere circle (TC) formation
as we show that the SLX4 nuclease complex is also responsible
for the formation of TCs that arise in ALT cells and in cells over-
expressing the dominant-negative TRF2DB. Furthermore, we
demonstrate that RTEL1 and BLM operate in genetically distinct
pathways to counteract telomere fragility, and we establish that
telomeric G4-DNA structures are a major source of telomere
fragility in RTEL1-deficient cells. Thus, our findings define the
mechanistic basis of T loop disassembly and provide insight
into the source and prevention of telomere fragility, which reflect
two distinct activities of RTEL1 at telomeres.
RESULTS
Conditional Deletion of RTEL1 Results in Telomere
Abnormalities
To investigate the telomere function of mammalian RTEL1, we
established a conditional allele of the mouse RTEL1 gene that
permits Cre-mediated deletion of exon 7, resulting in the prema-
ture termination of the RTEL1 coding sequence (Wu et al., 2007).
Infection of RTEL1F/ mouse embryonic fibroblasts (MEFs) with
a Cre-expressing adenovirus resulted in the loss of the floxed
RTEL1 allele and elimination of the RTEL1 protein within 72 hr
(Figures 1A and 1B).
Cre-mediated deletion of RTEL1 resulted in reduced prolifera-
tive capacity, induction of senescence, and accumulation of
sister chromatid breaks on 11%of chromosomes permetaphase
(Figure S1 available online). Analysis of metaphases in RTEL1F/
MEFs by telomere fluorescence in situ hybridization (FISH) 96 hr
after Cre-infection also revealed various striking telomere abnor-
malities (Figures 1C and S1). In wild-type (WT) cells, telomere
FISH signals are present on each individual sister chromatid
end, and the intensity of the FISH signal is comparable between
each sister chromatid. Following conditional inactivation of
RTEL1, the intensity of the telomere FISH signal was significantly
reduced or increased on a given sister chromatid end relative
to the other sister, suggestive of a rapid alteration in telomere
length (Figures 1C and 1D). We also detected a high incidence
of chromosomes inRTEL1/ cells that lacked a detectable telo-
mere FISH signal on one or both sister chromatid ends, indicative
of complete telomere loss (Figures 1C and 1D). In agreement
with a recent report (Sfeir et al., 2009), we also detected a high
incidence of fragile telomeres following inactivation of RTEL1
that manifests as sister chromatid ends with multiple spatially
separated telomere FISH signals (Figures 1C and 1D). Analysis
of telomere length by quantitative telomere FISH confirmed that
loss of RTEL1 leads to rapid alteration in the mean telomere796 Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc.length, which included a statistically significant increase in both
short and long telomeres (Figure 1E) (Ding et al., 2004).
Because inactivation of either RTEL1 or TRF1 confers a fragile
telomere phenotype (Sfeir et al., 2009), we performed a direct
comparison of telomere phenotypes in conditional knockout
MEFs. Inactivation of RTEL1 resulted in loss of the telomere
FISH signal on 18 ± 2 chromosome ends per metaphase. This
contrasted with the loss of less than 2 ± 1 telomeres per meta-
phase in RTEL1+/ and TRF1/ cells (Figure 1F). Confirming a
recent report, inactivation of either TRF1 or RTEL1 resulted in
17 ± 2 and 12 ± 3 fragile telomeres per metaphase, respectively
(Figure 1G) (Sfeir et al., 2009). RTEL1-deficient cells also showed
a significant induction of the DNA-damage response at telo-
meres, although this phenotype was not as strong as previously
reported in TRF1-deficent cells (Figure S1) (Sfeir et al., 2009). Our
data reveal that inactivation ofRTEL1 results in the accumulation
of several distinct telomere abnormalities, including rapid
changes in telomere length, telomere loss, and telomere fragility.
Although telomere fragility is a phenotype observed in both
RTEL1- and TRF1-deficient cells (Sfeir et al., 2009), the telo-
mere-length heterogeneity and loss of telomeres are only seen
following inactivation of RTEL1. This raises the possibility that
the phenotype of RTEL1-deficient cells may reflect at least two
distinct roles for RTEL1 at telomeres.
RTEL1 Can Disassemble T Loops In Vitro
RTEL1 was previously identified as an antirecombinase that acts
to constrain HR by disassembling D loop intermediates (Barber
et al., 2008). We reasoned that the ability of RTEL1 to disas-
semble preformed D loops during conventional HR reactions
may have been co-opted to dismantle T loop structures that
are believed to form at telomeres when the 30 single-stranded
end of the telomere invades into double-stranded telomere
repeats to form a lasso-like structure (Griffith et al., 1999), which
contains a D loop at the site of strand invasion (de Lange, 2005).
To determine whether RTEL1 is capable of disrupting a T loop
structure in vitro, we employed a T loop assay developed by
Verdun and Karlseder (Verdun and Karlseder, 2006). In this
assay, a radiolabeled telomere repeat fragment containing
a single-stranded DNA end was shown to undergo strand inva-
sion into a telomere repeat containing plasmid to form a T loop
in the presence of cell extracts (Figure S2A). Critically, T loop
formation required HR factors as well as the shelterin compo-
nents TRF1 and TRF2 as their depletion from the extract abol-
ished T loop formation in vitro (Verdun and Karlseder, 2006).
To determine whether RTEL1 impacts on T loop formation in
this assay, we generated extracts from control cells and cells
induced to express either the WT or the ATPase dead mutant
(K48R) of RTEL1 (Figure S2B). T loop structures were readily de-
tected as a slower-migrating band on agarose gels in control
extracts (-Tet; Figure S2C, lanes 3 and 5) but not when either
the extract or the plasmid substrate was omitted (Figure S2C,
lanes 1 and 2). Furthermore, T loops formed in cell extracts ex-
pressing the K48R mutant of RTEL1 (Figure S2C, lane 6) but
not in extracts expressing WT RTEL1 (Figure S2C, lane 4). Addi-
tionally, T loops only formed with telomere repeat fragments
containing a 30 single-stranded end (Figure S2C, lanes 3 to 6)
but not with a 50 single-stranded end (Figure S2C, lanes 7–10),
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Figure 1. Telomere Defects Resulting from Conditional Deletion of Mouse RTEL1
(A) RTEL1 genotyping PCR on DNA derived from MEFs of the indicated genotypes. PCR products: WT, 571 bp; flox, 812 bp; null allele, 777 bp.
(B) Immunoblots to monitor loss of RTEL1 upon Cre-treatment of RTEL1F/+ and RTEL1F/ MEFs. Tubulin WB as loading control.
(C and D) Telomere FISH to monitor telomere integrity upon loss of RTEL1, 96 hr after Cre-treatment. Representative low (C) and high (D) magnification images of
chromosomes fromWT andRTEL1/MEFs. Three classes of telomere dysfunction are observed inRTEL1/MEFs: telomere heterogeneity, red; telomere loss,
yellow; telomere fragility, pink.
(E) Quantitative telomere FISH analysis to monitor telomere length in RTEL1+/ and RTEL1/ MEFs (significance: one-way ANOVA, p < 0.001).
(F and G) Quantification of (F) telomere loss and (G) telomere fragility per metaphase before and 96 hr post Cre-treatment in MEFs of the indicated genotype.Error
bars indicate ± standard error of the mean (SEM) from at least 50 metaphases.
See also Figure S1.which conforms to the physiological orientation of strand inva-
sion by HR. These results demonstrate that RTEL1 can disas-
semble or prevent the formation of T loops in vitro, and this
requires its ATPase activity. This finding raised the possibility
that telomere loss in RTEL1-deficient cells may reflect a failure
to efficiently dismantle T loops in vivo.
TCs Rapidly Accumulate following Inactivation ofRTEL1
We speculated that the rapid loss of telomeres in the absence of
RTEL1 could arise if persistent T loops were inappropriately pro-
cessed to produce a TC. Previous studies have shown that TCs
form at a high frequency in cells that overexpress the dominant-
negative TRF2DB and also in ALT cells, which maintained telo-
meres by recombination in the absence of telomerase (Henson
et al., 2009; Wang et al., 2004). To determine whether TCs alsoaccumulate following inactivation of RTEL1, we developed
a TC amplification assay based on a previous method used to
detect TCs in plants (Zellinger et al., 2007). In this assay, a telo-
mere-specific oligonucleotide is annealed with denatured
genomic DNA and subject to rolling circle amplification by
Phi29 polymerase. The amplified telomere products are resolved
on denaturing gels and detected by telomere repeat Southern
blot (Figure 2A). The product of TC amplification can be distin-
guished from linear telomere repeat fragments (TRFs) by the
fact that TRFs are significantly retarded on gel (Zellinger et al.,
2007). Specificity of the TC amplification is based on the resis-
tance of circular DNA to treatment with exonuclease V (ExoV)
compared to linear TRFs that are degraded by ExoV (Zellinger
et al., 2007). As a proof of principle, we used the TC amplification
assay on TRF2DB-overexpressing cells and in VA13 ALT cells,Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc. 797
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Figure 2. TCs Rapidly Accumulate upon Conditional Deletion of Mouse RTEL1
(A) Schematic of the method employed to detect TCs by Phi29 rolling circle amplification with a telomere-specific primer.
(B) Phi29-dependent TCs in NIH 3T3 control, TRF2DB-overexpressing cells, and VA13 ALT cells.
(C) Linear TRFs and Phi29-dependent TCs detected 96 hr post Cre-treatment of RTEL1F/ MEFs. VA13 ALT cells were used as control for TC amplification.
(D) Graphical representation of levels of linear TRFs and Phi29-dependent TCs detected 96 hr post Cre-treatment of RTEL1F/ MEFs untreated or treated
with ExoV.
(E) Graphical representation of the fold induction of Phi29-dependent TCs in RTEL1F/+ and RTEL1F/ MEFs at the indicated time points post-treatment with Cre.
VA13 ALT cells were used as control for TC amplification. Error bars indicate ± SEM from at three independent experiments.
See also Figure S2.which confirmed the presence of TCs as previously reported
(Figure 2B) (Henson et al., 2009; Wang et al., 2004).
To determine whether telomere loss in RTEL1-deficient cells
correlates with the accumulation of TCs, we employed the TC
amplification assay on conditional RTEL1F/ MEFs. A low basal
level of Phi29-dependent TCs was detected in untreated
RTEL1F/ cells. In contrast, very high levels of Phi29-dependent
TCs were detected in RTEL1-deficient cells 96 hr post-treatment
with Cre (Figure 2C). Importantly, incubation of genomic DNA
with ExoV prior to Phi29 rolling circle amplification abolished
the linear TRF signal but had no effect on TCs, confirming that
the amplified products arise from circular species (Figure 2D).
To examine the dynamics of TC formation following inactivation
of RTEL1, we performed a time course analysis following RTEL1
inactivation. Phi29-dependent TCs were readily detected 24 hr
after Cre-infection ofRTEL1F/ cells and increased progressively
up to 96 hr after Cre-infection to levels exceeding those
observed in VA13 ALT cells, which acted as a positive control
(Figure 2E). Thus, TCs rapidly accumulate following inactivation
of RTEL1, which suggests that telomere loss results from exci-
sion of the telomere as a circle within two to three cell cycles.
Inhibiting DNA Replication Exacerbates Telomere
Fragility but Blocks TC Formation and Telomere Loss
in RTEL1-Deficient Cells
The fragile telomeres that accumulate in TRF1-deficient cells
resemble common fragile sites as both events are respectively798 Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc.increased and induced following treatment with aphidicolin,
which inhibits DNA polymerase and blocks replication (Durkin
and Glover, 2007; Sfeir et al., 2009). To examine the impact of
replication inhibition on the telomere phenotype of RTEL1-
deficient cells, we examined metaphases of RTEL1-proficient
and -deficient MEFs treated with a low concentration of aphidi-
colin (0.2 mM). Aphidicolin treatment led to a modest induction
of telomere fragility in RTEL1-proficient cells (Sfeir et al., 2009)
and a substantial increase in the number of fragile telomeres in
RTEL1-deficient cells, corresponding to an increase from 11 ±
3 fragile telomeres permetaphase showing fragility without treat-
ment to 21 ± 2 following treatment with aphidicolin (Figure 3A).
These results suggest that the fragile telomeres arising following
inactivation of RTEL1 resemble common fragile sites, as is the
case in TRF1-deficient cells (Sfeir et al., 2009).
To investigate the impact of replication inhibition on the
accumulation of TCs in RTEL1-deficient cells, we examined TC
formation in RTEL1-proficient and -deficient cells following
treatment with aphidicolin. Strikingly, aphidicolin treatment
(5 mM) completely abolished Phi29-dependent TC amplification
following inactivation of RTEL1 (Figure 3B). TC formation was
also abolished in RTEL1-deficient cells following treatment
either with a lower concentration of aphidicolin (0.5 mM) or with
hydroxyurea (3 mM), which stalls replication by inhibition of
ribonucleotide reductase (Figure 3C). If telomere loss in
RTEL1-deficient cells results from excision of the T loop as a
circle then aphidicolin treatment should also suppress the
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Figure 3. Effect of Blocking DNA Replication on the Telomere Phenotype of RTEL1-Deficient Cells
(A) Representative images of telomere fragility in RTEL1/ MEFs as assessed by telomere FISH. Quantification of fragile telomeres per metaphase in RTEL1F/+
and RTEL1F/ MEFs in the presence or absence of the replication inhibitor aphidicolin (Apd; 0.2 mM) before and 96 hr after Cre-treatment are shown. Error bars
indicate ± SEM from at least 50 metaphases.
(B) Phi29-dependent TCs in RTEL1/ MEFs in the presence or absence of the replication inhibitor aphidicolin (Apd; 5 mM).
(C) Quantification of the fold induction of Phi29-dependent TCs in RTEL1/ MEFs subject to the indicated treatments (no treatment, ; aphidicolin, Apd;
Hydroxyurea, HU).
(D) Quantification of telomere loss per metaphase inRTEL1F/MEFs in the presence or absence of aphidicolin (Apd; 0.2 mM) before and 96 hr after Cre-treatment
(significance: one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.frequency of telomere loss following RTEL1 inactivation. Indeed,
aphidicolin treatment led to a substantial reduction in the
frequency of telomere loss in RTEL1-deficient cells, correspond-
ing to a statistically significant (p < 0.05) reduction from 12 ± 5
telomere loss per metaphase in untreated RTEL1/ cells to
4.5 ± 1.8 telomere loss per metaphase following treatment with
aphidicolin, which is comparable to the telomere loss observed
in RTEL1-proficient cells (Figure 3D). These results suggest
that loss of telomeres in RTEL1-deficient cells results from exci-
sion of the telomere as a circle, which requires active DNA
replication.
TC Formation and Telomere Loss in RTEL1-Deficient
Cells Are SLX4 Dependent
We next focused our efforts toward understanding the mecha-
nism of TC formation and telomere loss in RTEL1 null cells. We
reasoned that a persistent T loop could be cleaved at the site of
strand invasion by a structure-specific nuclease and repaired
as a crossover, which would result in loss of the telomere as
a circle. Intriguingly, the human SLX4 nuclease complex was
recently shown to associatewith telomeres based onproteomics
of isolated chromatin (PICh) segments data (De´jardin and King-
ston, 2009), its interaction with the shelterin components Rap1and TRF2 (Fekairi et al., 2009; Svendsen et al., 2009), and its co-
localization with Rap1 at telomeres in immunofluorescence (IF)
experiments (Svendsen et al., 2009). Moreover, biochemical
studies have established that the SLX4 nuclease complex
exhibits resolution activity toward D loop and Holliday junction
intermediates that are believed to form at the site of strand
invasion of the T loop (Fekairi et al., 2009; Mun˜oz et al., 2009;
Svendsen et al., 2009). Thus, the SLX4 nuclease complex is
located at telomeres and possesses the appropriate nucleolytic
activity to excise the T loop as a circle in RTEL1-deficient cells.
To test this possibility, we first assessed the contribution of
the SLX4 subunit of this complex, which is believed to function
as a scaffold protein that binds directly to each of the three
nucleases in the complex (MUS81, XPF, and SLX1) (Svendsen
and Harper, 2010). Strikingly, TC formation was completely
abolished in RTEL1/ MEFs stably expressing SLX4 shRNA
but not with control shRNA (Figures 4A and 4B). Importantly,
analysis of cell-cycle profiles of these cells excluded that the
effect of SLX4 depletion on TC formation is an indirect conse-
quence of a block to DNA replication (Figure S3A). To determine
whether the suppression of TC formation in RTEL1-deficient
cells also rescues telomere loss and to exclude potential
off-target effects of SLX4 shRNA, we analyzed metaphaseCell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc. 799
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Figure 4. Effect of SLX4 Downregulation on the Telomere Phenotype of RTEL1-Deficient Cells
(A) Phi29-dependent TCs in RTEL1/ MEFs subjected to control or SLX4 shRNAs.
(B) Quantification of the fold induction of Phi29-dependent TCs in RTEL1/ MEFs subjected to control or SLX4 shRNAs.
(C) Quantification of telomere loss per metaphase in RTEL1F/MEFs subjected to control or SLX4 shRNAs (two independent SLX4 shRNAs: n1 and n2) before
and 96 hr after Cre-treatment (significance: one-way ANOVA, p < 0.05). Error bars indicate ± SEM from three independent experiments.
(D) Quantification of fragile telomeres per metaphase in RTEL1F/MEFs subjected to control or SLX4 shRNAs before and 96 hr after Cre-treatment (significance:
one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.
See also Figures S3 and S4.spreads in RTEL1-proficient and -deficient cells expressing
two different SLX4 shRNAs (Figure S4, sh1 and 2). In RTEL1-
proficient cells (Cre), stable knockdown of SLX4 had no
measurable effect on telomere loss (Figure 4C). In agreement
with our previous results, RTEL1-deficient cells treated with
control shRNA exhibited a high frequency of telomere loss
(+Cre: 19 ± 6.7 telomere loss per metaphase) when compared
to RTEL1-proficient cells (Cre: 3.3 ± 1.3 telomere loss per
metaphase). In contrast, stable knockdown of SLX4 in RTEL1-
deficient cells resulted in a striking suppression of the telomere
loss phenotype (Figure 4C). Analysis of telomere length by
quantitative telomere FISH revealed that SLX4 knockdown also
suppressed the increase in both short and long telomeres in
RTEL1-deficient cells (Figure S3B). However, SLX4 knockdown
neither induced telomere fragility alone nor rescued the fragile
telomere phenotype of RTEL1/ cells (Figure 4D). These results
demonstrate that SLX4 is required for TC formation and telomere
loss in RTEL1-deficient cells, but it has no measurable effect on
telomere fragility.800 Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc.To determine whether our findings reflect a general mecha-
nism of TC formation, we next assessed whether active DNA
replication and the SLX4 complex are also required for TC forma-
tion in ALT cells or TRF2DB-overexpressing cells, which also
accumulate TCs (Figure 2B) (Henson et al., 2009; Wang et al.,
2004). Treatment of VA13 ALT cells with 0.5 mM aphidicolin
completely suppressed TC formation (Figure S5A). Moreover,
the stable knockdown of SLX4 in VA13 ALT with four different
shRNAs (sh1–4) resulted in a substantial decrease in TCs when
compared to VA13 ALT cells expressing a control shRNA (Fig-
ure S5A). In agreement with previous data, overexpression of
TRF2DB, but not WT TRF2, in NIH 3T3 cells induced high levels
of TCs (Wang et al., 2004). Treatment of TRF2DB-overexpress-
ing cells with 0.5 mM aphidicolin or stable expression of SLX4
shRNA led to amarked reduction in the level of TCs (Figure S5B).
These results establish that TC formation in ALT cells, RTEL1-
deficient cells, or cells overexpressing TRF2DB occurs by a
common mechanism that requires active DNA replication and
the SLX4 nuclease complex.
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Figure 5. Effect of MUS81, ERCC1, and SLX1 Downregulation on the Telomere Phenotype of RTEL1-Deficient Cells
(A) Phi29-dependent TCs in RTEL1/ MUS81/ double-knockout MEFs and controls.
(B) Phi29-dependent TCs in RTEL1/ MEFs subjected to control, SLX4, SLX1, or ERCC1 shRNAs (two independent shRNAs for each: n1 and n2).
(C) Quantification of the fold induction of Phi29-dependent TCs in RTEL1/ MEFs subjected to control, SLX4, SLX1, or ERCC1 shRNAs.
(D) Quantification of telomere loss per metaphase in RTEL1/ MEFs subjected to control, SLX1, or ERCC1 shRNAs (significance: one-way ANOVA, p < 0.05).
Error bars indicate ± SEM from at least 50 metaphases.
(E) Quantification of fragile telomeres per metaphase inRTEL1/MEFs subjected to control, SLX1, or ERCC1 shRNAs (significance: one-way ANOVA, p < 0.05).
Error bars indicate ± SEM from at least 50 metaphases.
See also Figure S5.SLX1 and ERCC1/XPF, but Not MUS81, Are Required for
TC Formation and Telomere Loss in RTEL1-Deficient
Cells
To determine which of the three nucleases present in the SLX4
complex are responsible for TC formation and telomere loss in
the absence of RTEL1, we generated RTEL1/ MUS81/
double-knockout MEFs (Dendouga et al., 2005) and established
RTEL1F/ MEFs stably expressing shRNAs to SLX1 and ERCC1
(Figure S4). The levels of TCs in RTEL1/ MUS81/ double-
knockout MEFs was comparable to RTEL1/ cells alone
(Figures 5A and 5C), demonstrating that MUS81 is dispensable
for TC formation in the absence of RTEL1. In contrast, RTEL1/
MEFs stably expressing two different shRNAs to SLX1 or to
ERCC1 exhibited markedly decreased levels of TCs, which
was comparable to the suppression of TCs observed in
RTEL1-deficient cells subjected to SLX4 shRNA knockdown
(Figures 5B and 5C). To confirm these results, we also assessed
telomere loss in RTEL1-deficient cells. Knockdown of either
SLX1 or ERCC1 resulted in a substantial rescue of the telomere
loss phenotype in RTEL1-deficient MEFs (Figure 5D). However,
SLX1 or ERCC1 knockdown failed to rescue the fragile telomerephenotype of RTEL1/ cells (Figure 5E). These results demon-
strate that the SLX4-associated nucleases SLX1 and ERCC1/
XPF both contribute to the formation of TCs and the resultant
loss of telomeres in RTEL1-deficient cells, but like SLX4, neither
nuclease has an impact on telomere fragility.
Telomere Fragility, but Not Telomere Loss,
in RTEL1-Deficient Cells Is Exacerbated by Loss of BLM
A role for RTEL1 in controlling HR was first suggested by the
synthetic lethality of rtel-1; him-6 (Sgs1/BLM) double mutants
in C. elegans, which die as a result of the accumulation of toxic
recombination intermediates (Barber et al., 2008). Intriguingly,
a recent study reported that knockdown of either BLM or
RTEL1 results in telomere fragility in vertebrate cells (Sfeir
et al., 2009), but whether or not BLM and RTEL1 function
together or in genetically distinct pathways to avert telomere
fragility was not addressed. We therefore generated RTEL1F/
BLM/ MEFs to examine the relationship between BLM and
RTEL1 in telomere maintenance (Figure S4) (Luo et al., 2000).
A comparison of BLM/ cells and RTEL1/ cells revealed
that only RTEL1-deficient cells accumulate high levels of TCs,Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc. 801
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Figure 6. Effects of BLM and the G-Quadruplex-Stabilizing Agent TMPyP4 on RTEL1/ MEFs for TC Formation, Telomere Loss, and
Telomere Fragility
(A) Phi29-dependent TCs in TRF1/, BLM/, and RTEL1/ MEFs.
(B) Quantification of telomere loss per metaphase in BLM+/+RTEL1F/ and BLM/RTEL1F/ MEFs before and 96 hr post-treatment with Cre (significance:
one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.
(C) Quantification of fragile telomeres per metaphase in BLM+/+RTEL1F/ and BLM/RTEL1F/ MEFs before and 96 hr post-treatment with Cre (significance:
one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.
(D) Quantification of the fold induction of Phi29-dependent TCs in RTEL1/ MEFs treated for 72 hr after Cre with TMPyP4 (10 mM), compared to untreated cells
and cells treated with aphidicolin (Apd, 0.5 mM). Error bars indicate ± SEM from at least 50 metaphases.
(E) Quantification of telomere loss per metaphase in RTEL1F/ and RTEL1/MEFs treated for 72 hr after Cre with TMPyP4 (10 mM), compared to untreated cells
(significance: one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.
(F) Quantification of fragile telomeres per metaphase in RTEL1F/ and RTEL1/ MEFs treated for 72 hr after Cre with TMPyP4 (10 mM), compared to untreated
cells (significance: one-way ANOVA, p < 0.05). Error bars indicate ± SEM from at least 50 metaphases.
See also Figure S6.suggesting that BLM does not significantly contribute to T loop
disassembly (Figure 6A).
In agreement with previous data, loss of either BLM or RTEL1
resulted in enhanced telomere fragility (15 ± 6.4 and 17 ± 7.2
fragile telomeres per metaphase, respectively, compared to
5.2 ± 2.9 in controls; Figure 6C) (Sfeir et al., 2009). Strikingly,
RTEL1/ BLM/ double-knockout cells displayed an additive
effect on telomere fragility, corresponding to 28 ± 15 fragile
telomeres per metaphase (Figure 6C). Further analysis of meta-
phase spreads of BLM-deficient cells revealed a low frequency
of telomere loss relative to cells lacking RTEL1, which corre-
sponded to an average of 3.1 ± 1.6 telomere loss per metaphase
in BLM/ MEFs and 12 ± 5.2 in RTEL1/ MEFs (Figure 6B). In
contrast to the additive effect on telomere fragility, the levels of
telomere loss in RTEL1/ BLM/ double-knockout cells were
not statistically different from those in RTEL1-deficient cells
(average of 13 ± 5.2 telomere loss in RTEL1/ BLM/ MEFs
compared with 12 ± 5.2 in RTEL1/ MEFs; Figure 6B). These802 Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc.results suggest that RTEL1 and BLM function in distinct path-
ways to suppress telomere fragility. Moreover, BLM does not
have a significant impact on telomere loss either alone or in
combination with RTEL1.
Stabilization of G4-DNA Structures Exacerbates
Telomere Fragility in RTEL1-Deficient Cells
but Has No Impact on Telomere Loss
It has been speculated that telomere fragility reflects a problem
replicating telomere repeats, which have been reported to adopt
G4-DNA secondary structures that could hinder DNA replication
(Gilson and Ge´li, 2007; Sfeir et al., 2009). However, in vivo
evidence linking G4-DNA secondary structures to telomere
fragility remains lacking. We reasoned that if G4-DNA secondary
structures are a source of telomere fragility, then stabilization of
G4-DNA structures should exacerbate the fragile telomere
phenotype. To test this possibility, we treated RTEL1-deficient
cells with the G4-DNA-stabilizing drug TMPyP4 (Izbicka et al.,
!Telomere loss, Telomeric circles
Telomere recombination
S
G1
T-loop
persistent T-loop
RTEL1 T-loop
disassembly
Full replication of
telomere
SLX4 dependent
nucleolytic
resolution
Replication through 
telomeric G4-DNA 
structures
Telomere fragility
S
G4-DNA
BLM
RTEL1
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
BA
Wild Type RTEL1-/- Wild Type RTEL1-/-
SLX4
SLX1ERCC1
RTEL1
Figure 7. Schematic Model of the Dual Role of RTEL1 in Disassembling T Loops and Suppressing Telomere Fragility
(A) RTEL1 disassembles T loop secondary structures to allow replication of the chromosome end. In the absence of RTEL1, persistent T loops are inappropriately
resolved by the SLX4 nuclease complex (SLX1- and XPF-dependent manner), resulting in the formation of TCs and telomere loss.
(B) RTEL1 and BLM function in distinct pathways to suppress G4-DNA structures to facilitate replication of the telomere. In the absence of RTEL1, G4-DNA
structures are a major source of telomere fragility.1999) and examined TC formation, telomere loss, and telomere
fragility. Treatment of RTEL1-deficient cells with TMPyP4
(10 mM) had no measurable effect on TC formation, whereas
treatment with aphidicolin (Apd, 5 mM) blocked TC formation
(Figure 6D). Furthermore, telomere loss was comparable
between untreated RTEL1-deficient cells and those treated
with TMPyP4 (Figure 6E). Strikingly, however, TMPyP4 treatment
resulted in a dramatic elevation in telomere fragility in RTEL1-
deficient cells, corresponding to 31 ± 11 fragile telomeres per
metaphase following TMPyP4 treatment compared to 20 ± 5.9
fragile telomeres per metaphase without treatment (Figure 6F).
Collectively, these results demonstrate that G4-DNA secondary
structures are a major source of telomere fragility in the absence
ofRTEL1, but stabilization of these structures has nomeasurable
impact on TC formation and telomere loss.
DISCUSSION
The existence of T loop structures at human telomeres was first
described over a decade ago (Griffith et al., 1999). Subsequent
studies have confirmed that T loops also form in other species
(Cesare et al., 2003; Mun˜oz-Jorda´n et al., 2001; Raices et al.,
2008), and investigation into the factors that promote T loop
assembly revealed that this structure corresponds to a special-
ized HR intermediate formed by HR and shelterin componentsthat catalyze strand invasion of the 30 single-stranded end of
the telomere into proximal double-stranded telomere repeats
(de Lange, 2005; Verdun and Karlseder, 2006). Here we establish
that the helicase RTEL1 plays a critical role in the disassembly of
T loops, and we provide mechanistic insight into the dramatic
consequences of a failure to disassemble T loops effectively
(Figure 7A). In addition to promoting T loop disassembly, we
establish that RTEL1 performs a second distinct function
required to avert telomere fragility caused by G4-DNA structures
that form from telomere repeats (Figure 7B).
RTEL1 Dismantles T Loops to Prevent Catastrophic
Telomere Processing by the SLX4 Resolvasome
RTEL1 was previously implicated as an antirecombinase that
acts by disrupting D loops formed during HR (Barber et al.,
2008). During DNA repair, RTEL1 activity is employed to coun-
teract toxic recombination intermediates, whereas in meiosis
this activity is believed to promote synthesis-dependent strand
annealing to limit crossing over (Barber et al., 2008; Youds
et al., 2010). Our current findings establish that the telomere
loss and rapid changes in telomere length observed in RTEL1-
deficient cells reflects a defect in the efficient disassembly of T
loops. We propose that the D loop disruption activity of RTEL1
is required to displace the 30 end of the telomere to allow efficient
unwinding of T loops (Figure 7A).Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc. 803
In support of this hypothesis, we found thatWTRTEL1, but not
an ATPase-dead mutant, is able to antagonize the formation of a
T loop structure formed in vitro. In vertebrate cells, we observed
that conditional inactivation of RTEL1 results in the rapid accu-
mulation of TCs, whose formation is coincident with rapid
changes in telomere length and telomere loss. We attribute TC
formation and telomere loss to the inappropriate resolution of
the T loop as a circle as downregulation of SLX4 or its associated
nucleases, SLX1 or ERCC1/XPF, rescues these phenotypes
(Figure 7A). Previous studies have shown that the SLX4 nuclease
complex is a Holliday junction-resolving enzyme that interacts
with TRF2 and Rap1 and colocalizes with Rap1 at telomeres
(Fekairi et al., 2009; Mun˜oz et al., 2009; Svendsen et al., 2009).
Our findings suggest that the resolution activity of the SLX4
nuclease complex resolves T loops that persist in the absence
of RTEL1. Depending on the orientation of nucleolytic cleavage,
processing of the T loop is predicted to result in a crossover and
loss of the telomere as a circle (de Lange, 2005). Double-strand
breaks formed following incision of the T loop could also recom-
bine with another telomere leading to telomere addition or loss
(Wang et al., 2004). Consistent with this hypothesis, RTEL1-
deficient cells exhibit elevated telomere recombination frequen-
cies, which manifest as telomere sister chromatid exchanges
(Figure S6).
Our observation that TC formation and telomere loss in
RTEL1-deficient cells are suppressed by blocking DNA replica-
tion raises the possibility that persistent T loops are removed
during S phase (Gilson and Ge´li, 2007). It is possible that resolu-
tion of persistent T loops inRTEL1 null cells is triggered by a colli-
sion between the T loop and the replisome. Alternatively, positive
supercoiling in front of the advancing replication fork could result
in a change in T loop conformation that ‘‘opens up’’ the telomere
to allow access to the D loop, thus limiting access only when the
telomere is replicated. In normal cells, we presume that RTEL1
accesses the T loop preferentially, but in the absence of
RTEL1 or in the event that T loops persist in WT cells, the
SLX4 nuclease complex gains access to the D loop, leading to
resolution of the T loop as a circle. It is possible that RTEL1 is
only transiently associated with the telomere during S phase to
facilitate T loop disassembly. However, attempts to test this
possibility have been hampered by the fact that RTEL1 is ex-
pressed at very low levels in cells and its overexpression confers
cellular toxicity; the former likely explains the absence of RTEL1
in PICh analysis of telomeres (De´jardin and Kingston, 2009).
Function of the SLX4 Resolvasome at Telomeres
SLX4 and its associated nucleases MUS81, ERCC1/XPF, and
SLX1 were previously shown to associate with telomeres and
to colocalize with the shelterin components TRF2 and Rap1 (Fe-
kairi et al., 2009; Svendsen and Harper, 2010; Svendsen et al.,
2009). However, the function of SLX4 at telomeres had not
been investigated. In agreement with recent studies implicating
SLX4 in Fanconi Anemia, we found that downregulation of
SLX4 in mouse cells led to the accumulation of radial chromo-
somes (Crossan et al., 2011; Stoepker et al., 2011). However,
depletion of SLX4, SLX1, or ERCC1/XPF did not lead to the
accumulation of TCs nor result in telomere loss or telomere
fragility, suggesting that the SLX4 nuclease complex does not804 Cell 149, 795–806, May 11, 2012 ª2012 Elsevier Inc.perform a critical role in telomere maintenance. Instead, our
results raise the possibility that the SLX4 nuclease complex is
located at telomeres to resolve persistent HR intermediates
that may arise infrequently in normal cells. In contrast, RTEL1-
deficient cells represent the extreme scenario where T loops
persist and SLX4 resolvase activity toward these structures
leads to catastrophic consequences for telomere integrity.
A General Mechanism of TC Formation in Vertebrate
Cells
Our analysis of RTEL1-deficient cells has also revealed pheno-
typic similarities to ALT cells and to cells overexpressing
TRF2DB, including telomere-length heterogeneity and the
presence of TCs (Henson et al., 2002, 2009; Wang et al.,
2004). We show here that the formation of TCs occurs by a
common mechanism as TC formation in ALT cells and in cells
overexpressing TRF2DB is also suppressed by blocking DNA
replication or downregulation of the SLX4 resolvasome. Our find-
ings that RTEL1-deficient cells and ALT cells share phenotypic
characteristics raise the possibility that downregulation of
RTEL1 in cancer cells is a prerequisite to the acquisition of
ALT. Although the expression status of RTEL1 in ALT cells has
not been investigated in any detail, it is intriguing to note that
RTEL1 and TERT are susceptibility loci for glioma (Egan et al.,
2011; Jenkins et al., 2011; Shete et al., 2009), which maintain
telomeres by an ALT mechanism (Silvestre et al., 2011).
Telomere Fragility: The Role of RTEL1 and Telomeric
G4-DNA Structures
Evidence from fission yeast and vertebrate cells has established
that telomeres are problematic structures for DNA replication
(Miller et al., 2006; Sfeir et al., 2009). Deletion of Taz1 in yeast
leads to rapid telomere loss and replication fork stalling within
telomere repeats (Ferreira and Cooper, 2001; Miller et al.,
2006). Similarly, mouse cells deficient for TRF1, the vertebrate
homolog of Taz1, exhibit fragile telomeres that resemble
common fragile sites as both are respectively increased and
induced by low doses of aphidicolin (Sfeir et al., 2009). Telomere
fragility manifests as multiple distinct telomere FISH signals at
chromosomes ends, which are believed to represent incomplete
regions of DNA replication and/or stalled replication forks (Sfeir
et al., 2009). Indeed, reduced replication fork rates and
increased fork stalling at telomeres were readily detectable in
TRF1-deficient cells (Sfeir et al., 2009).
Our finding that telomere fragility is exacerbated by treatment
with TMPyP4, a G4-DNA-stabilizing drug (Izbicka et al., 1999),
provides in vivo evidence that telomeric G4-DNA structures are
a major source of telomere fragility in vertebrates cells, which
is in agreement with studies of G4-DNA structures in yeast
(Paeschke et al., 2010; Ribeyre et al., 2009). It has been
proposed that TRF1 acts to suppress telomere fragility by
recruiting RTEL1 and BLM, which could unwind telomeric
G4-DNA structures (Sfeir et al., 2009). Our results further refine
this model as we establish that RTEL1 and BLM likely act in
different pathways to facilitate telomeric DNA replication
based on the enhanced fragile telomere phenotype observed
in RTEL1/BLM/ double-mutant cells relative to single-
knockout cells. Notably, the severity of telomere fragility in
RTEL1/BLM/ double-mutant cells is comparable to the
phenotype of TRF1-deficient cells (Sfeir et al., 2009). It is there-
fore possible that TRF1 independently recruits RTEL1 and
BLM via distinct interaction motifs. Alternatively, RTEL1 and
BLM may dismantle different telomeric G4-DNA structures that
each contribute to telomere fragility (Figure 7B).
EXPERIMENTAL PROCEDURES
Isolation of MEFs and Cell Culture Procedures
RTEL1F/+ and RTEL1F/mice were as described in Wu et al. (2007), MUS81+/
mice were kindly provided by C. McGowan (Dendouga et al., 2005), and
BLM+/mice by A. Bradley (Luo et al., 2000). MEFs were isolated from embry-
onic day (E) 13.5 embryos and immortalized with pBR322 SV40-LT. Immortal-
izedMEFswere cultured in DMEMcontaining 10% fetal bovine serum. TRF1F/F
cells were kindly provided by T. de Lange (Sfeir et al., 2009), and WI 38VA13
ALT cells (ECACC) were cultured in DMEM containing 10% FBS. NIH 3T3
mouse cells were infected with pLPC-NMyc, pLPC-NMyc-TRF2, or pLPC-
NMyc-DeltaB-TRF2 (a gift from T. de Lange) to generate correspondent
overexpressing stable cell lines cultured in DMEM containing 10% FBS.
Cre-recombination was carried out with Ad5-CMV-Cre adenovirus (Vector
Biolabs) for 24, 48, or 96 hr as described by Celli and de Lange (2005). shRNAs
for SLX4, SLX1, and ERCC1 were introduced using three infections at 24 hr
intervals with either lentivirus or retrovirus followed by puromycin selection
(Table S1). Cells were either untreated or treated with aphidicolin (0.2 mM,
0.5 mM, 5 mM), hydroxyurea (3 mM), or TMPyP4 (10 mM) treatments for 72 hr
with a 2 hr of recovery before collection for TMPyP4-treated cells.
Genomic DNA Extraction and TC Amplification
MEFs were collected from two to three 10 cm plates at 70% confluence for
each condition. gDNA extraction was performed as described by Mun˜oz-
Jorda´n et al. (2001). gDNA was double digested by AluI/HinfI restriction
enzymes overnight before starting the TCA assay, which was performed as
previously described (Zellinger et al., 2007) with minor modifications: Phi29
DNA polymerization (MBI Fermentas) employed a mammalian telomere
primer, and Southern blotting used amammalian telomere probe for hybridiza-
tion. Southern blot images were captured and quantified with Storm 840
scanner and ImageQuant TL software (Amersham Biosciences).
Metaphase Spreads, FISH, and CO-FISH
Metaphase spreads were prepared as previously described (Bayani and
Squire, 2005;Wechsler et al., 2011). After 96 hr of Cre-induction with or without
treatment (aphidicolin, TMPyP4, shRNA), MEFswere incubated for 90minwith
colcemid prior to harvesting metaphase cells. MEFs were swollen in 0.075 M
KCl for 20 min then fixed in methanol/acetic acid (3:1) prior to spreading.
FISH was performed as previously described (Lansdorp et al., 1996) using
a FITC-(CCCTAA)3 PNA probe (Bio Synthesis). DNA was counterstained with
4,6-diamidino-2-phenylindole (DAPI) before the last PBS wash and addition
of Vectashield mounting media (Vector). For CO-FISH, cells were incubated
with 10 mM 50-BrdU:50-BrdC (3:1; Sigma) for 16–20 hr before harvesting.
Following metaphase spreading, BrdU/dC-substituted DNAs were digested
with ExoIII (Promega) and then probed with TelG-Cy3 at 1/3000 and TelC-Fitc
at 1/500. Digital images were captured with Zeiss Axio Imager M1 microscope
with an ORCA-ER camera (Hamamatsu) controlled by Volocity 4.3.2 software
(Improvision). Between 25 and 70 images were taken randomly from each
condition in order to count the respective phenotypes. Images were corrected
for background and merged with Adobe Photoshop. Telomere loss and telo-
mere fragility in each genotype/condition were analyzed for statistical signifi-
cance by unpaired t test using Prism version 4.0 statistical analyses software.
IF-FISH
RTEL1 floxed cells were infected with Cre-recombinase expressing adeno-
virus, grown for 96 hr in an 8-well culture slide, and fixed for 10 min at room
temperature (RT) in 2% paraformaldehyde. Cells were washed twice for
5 min in PBS, incubated for 30 min in blocking solution (1 mg/ml BSA, 3%
goat serum, 0.1% Triton X-100, 1 mM EDTA in PBS), and then incubatedwith primary antibody against 53BP1 (Novus, 1:1,000) and secondary antibody
(Sigma, 1,5000) for 1 hr and 30 min, respectively, in blocking solution with
5 min washes in PBS in-between. After dehydration of the cells, FISH experi-
ments were performed as described above.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and one table and can be found with this article online at
doi:10.1016/j.cell.2012.03.030.
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